Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Even in worst-case scenario, Roche will grow past biosimilar erosion in the U.S.: executive

fiercepharmaOctober 19, 2018

Tag: U.S. , Executive

PharmaSources Customer Service